A PHASE-II STUDY TESTING A COMBINATION CHEMOTHERAPY WITH EPIRUBICIN AND VINDESINE AS 2ND LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER

  • Authors:
    • JP SCULIER
    • G BUREAU
    • J THIRIAUX
    • J LECOMTE
    • P RECLOUX
    • MC BERCHIER
    • F KROLL
    • D BROHEE
    • P MOMMEN
    • M PAESMANS
    • R SERGYSELS
    • J KLASTERSKY
  • View Affiliations

  • Published online on: November 1, 1995     https://doi.org/10.3892/ijo.7.5.1175
  • Pages: 1175-1178
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The European Lung Cancer Working Party conducted a phase II trial to determine the activity of a salvage regimen with high dose epirubicin (120 mg/m(2) on day 1) and vindesine (3 mg/m(2) on day 1) in patients with advanced non-small cell lung cancer failing to respond to first-line chemotherapy containing cisplatin and/or carboplatin. Courses were repeated every 3 weeks and evaluation of antitumoral response was performed after the 2 first courses. A total of 53 patients were registered, 4 were not eligible and 42 were evaluable for response. Two (5%) objective responses were documented. Although the regimen was very well tolerated, based oh the results it has to be considered inactive.

Related Articles

Journal Cover

November 1995
Volume 7 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
SCULIER J, BUREAU G, THIRIAUX J, LECOMTE J, RECLOUX P, BERCHIER M, KROLL F, BROHEE D, MOMMEN P, PAESMANS M, PAESMANS M, et al: A PHASE-II STUDY TESTING A COMBINATION CHEMOTHERAPY WITH EPIRUBICIN AND VINDESINE AS 2ND LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER. Int J Oncol 7: 1175-1178, 1995
APA
SCULIER, J., BUREAU, G., THIRIAUX, J., LECOMTE, J., RECLOUX, P., BERCHIER, M. ... KLASTERSKY, J. (1995). A PHASE-II STUDY TESTING A COMBINATION CHEMOTHERAPY WITH EPIRUBICIN AND VINDESINE AS 2ND LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER. International Journal of Oncology, 7, 1175-1178. https://doi.org/10.3892/ijo.7.5.1175
MLA
SCULIER, J., BUREAU, G., THIRIAUX, J., LECOMTE, J., RECLOUX, P., BERCHIER, M., KROLL, F., BROHEE, D., MOMMEN, P., PAESMANS, M., SERGYSELS, R., KLASTERSKY, J."A PHASE-II STUDY TESTING A COMBINATION CHEMOTHERAPY WITH EPIRUBICIN AND VINDESINE AS 2ND LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER". International Journal of Oncology 7.5 (1995): 1175-1178.
Chicago
SCULIER, J., BUREAU, G., THIRIAUX, J., LECOMTE, J., RECLOUX, P., BERCHIER, M., KROLL, F., BROHEE, D., MOMMEN, P., PAESMANS, M., SERGYSELS, R., KLASTERSKY, J."A PHASE-II STUDY TESTING A COMBINATION CHEMOTHERAPY WITH EPIRUBICIN AND VINDESINE AS 2ND LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER". International Journal of Oncology 7, no. 5 (1995): 1175-1178. https://doi.org/10.3892/ijo.7.5.1175